ODI Pharma AB (publ) (NGM: ODI)
Health Care · Pharmaceuticals · SE
Skr1.81
-7.18% today · +41.4% 1Y
ODI Pharma AB (publ) (NGM: ODI) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.32M.
Over the last twelve months the share price has gained 41.4%, trading between 1.00 and 5.45.
Tweenvest scores ODI Pharma AB (publ) across four factors: quality 52/100, value 31/100. Its strongest factor is quality.
ODI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.32M
- Revenue (TTM)
- $3.40M
- P/E
- 16.69
- EPS
- 0.11
- Dividend yield
- —
- Beta (5Y)
- 0.90
- 52-week high
- Skr5.45
- 52-week low
- Skr1.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.33M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| JFL Life Sciences LimitedNSEI: JFLLIFE | $3.50M | Rs10.25 | +2.50% |
| Panjon LimitedBSE: 526345 | $3.41M | Rs19.24 | -11.62% |
| 60 Degrees Pharmaceuticals, Inc.NasdaqCM: SXTP | $3.40M | $0.92 | -4.33% |
| CTT Pharmaceutical Holdings, Inc.OTCPK: CTTH | $3.38M | $0.06 | +2.91% |
| Sanai Health Industry Group Company LimitedSEHK: 1889 | $3.31M | HK$0.17 | -10.99% |
| RedHill Biopharma Ltd.NasdaqCM: RDHL | $3.28M | $0.52 | -2.69% |
| Cadrenal Therapeutics, Inc.NasdaqCM: CVKD | $3.25M | $0.82 | -10.19% |
| Goldline Pharmaceutical LimitedBSE: 544759 | $3.22M | Rs32.50 | +4.94% |
Figures last refreshed Oct 11, 2026.